About Us
EN
ENCN
PhytomedicineJournal Home
Phytomedicine is primarily a therapy-oriented Journal. Phytomedicine publishes innovative studies on efficacy, safety, quality and mechanisms of action of specified plant extracts, phytopharmaceuticals and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of specified herbal medicinal products, herbal preparations and purified compounds which have a defined and consistent quality assuring reproducible pharmacological activity. Phytomedicine was founded in 1994 to focus and stimulate research in this particular field and to set internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy and safety of phytomedicines. The main aims of Phytomedicine are associated with the integration of phytopreparations into conventional/official medicine. The journal covers the following sections: Clinical pharmacology and toxicology (randomized, placebo controlled, double blind, and observational open label studies) Behavioural, mental, affective, and stress-associated disorders Age-associated disorders Neuropharmacology Endocrine pharmacology Metabolic syndrome and obesity Cancer Immunopharmacology, inflammation Infectious diseases Pulmonary, gastrointestinal, cardiovascular and urogenital diseases Systems biology Safety assessment, pre-clinical toxicology, interaction with drugs and adverse events of herbal preparations Pharmacokinetic of natural compounds Standardization of herbal preparations Legislation of botanicals Invited reviews The directions of Phytomedicine are known to provide profound scientific background in Herbal Medicinal Products, their reproducible Quality and evidence based therapeutic efficacy. Since then quality criteria and standardization methods were defined and the European Medical Agency has elaborated numerous guidelines for the conduction of clinical studies and preparation of Herbal Medicinal Products. In total 107 ESCOP monographs have been produced and submitted to EMA. Many new analytical methods and instruments were implemented both for analysis and standardization of herbal Substances, herbal preparations and their bioassays and tremendous work has been carried out to remain aligned with these intentions during the last 18 years. Nowadays important topics remain to be approached, such as harmonization of the regulatory frameworks in Europe, America, Asia and Australia or the legislation of various "botanicals", where strict differentiation of requirements for health claims of herbal medicinal product, dietary supplements and nutraceuticals are required. Phytomedicine is the companion title to the open access journal Phytomedicine Plus.
Publishing Model：
ISSN：0944-7113
|EISSN：1618-095X
|Publication Frequency：12 times a year
|Last updated on 01 May 2026 / Current volume： 声逦鋺 / Current issue：
More Details
Chinese Materia Medica
Impact Factor
Journal Impact Factor(JIF) 2024
躭.杚
Journal Citation Indicator(JCI) 2024
缗.声䟕
Web of Science Rank 2024:
鵝欄嵻沟穫 偌。喊乊沟。乊偌
# 声声/缗篫杚
96.15%
Q1
喊沟穫乊佥葤嵻穫喊妯乊 & 。鵣胦鵝欄乊胦乊沟穫嵻葤巨 胦乊枀喊。喊沟乊
# 声/鋺逦
98.89%
Q1
鵝㡶嵻葤胦嵻。鵣欄鵣佥巨 & 鵝㡶嵻葤胦嵻。巨
# 声炆/杚逦缗
95.6%
Q1
。㡶乊胦喊偌穫葤巨, 胦乊枀喊。喊沟嵻欄
# 鋺/篫缗
95.14%
Q1
CiteScore Metrics
CiteScore 2024
声声.炆
=
杚缗杚炆缗 Citation （2022-2024）
缗篫躭鋺 Article （2022-2024）
CiteScore Rank 2024
。肃陱卖⻊蠹陱蠹鵃锆囹㥌续 囹鵃罒 嵻⻊锆蠹㥌鵃囹锆嚷聸蠹 胦蠹罒嚷桧嚷鵃蠹
# 缗/声声缗
98.21%
Q1
鵝㛁囹㥌陱囹桧蠹憗锆嚷桧囹⻊ 偌桧嚷蠹鵃桧蠹
# 声声/声躭逦
94.05%
Q1
枀㥌憗茡 枀嚷详桧肃聸蠹㥌续
# 声声/声逦炆
92.95%
Q1
鵝㛁囹㥌陱囹桧肃⻊肃茡续
# 缗炆/杚缗声
91.9%
Q1
胦肃⻊蠹桧憗⻊囹㥌 胦蠹罒嚷桧嚷鵃蠹
# 缗杚/声篫篫
87.01%
Q1
